SCHEMBL7329145

SCHEMBL7329145

Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)N1CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC1)O2

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.50
PTGS2 P35354 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
ACHE P22303 7/20 0.43
MAOB P27338 1/20 0.43
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CACNA2D1 P54289 1/20 0.39
CACNA1B Q00975 1/20 0.39
CACNB1 Q02641 1/20 0.39
CACNA1C Q13936 1/20 0.39
MGLL Q99685 2/20 0.38
FAAH O00519 1/20 0.38
BCHE P06276 7/20 0.37
CAPN1 P07384 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8540688 0.89 PTGS1 (0.45) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL9690451 0.87 TSHR (0.49) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL7968813 0.81 PTGS1 (0.48) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL7335483 0.80 USP2 (0.54) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL2059305 0.79 PTGS1 (0.64) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL10367354 0.79 CYP3A4 (0.67) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL30534604 0.79 CYP3A4 (0.67) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL8543897 0.78 TTPA (0.42) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL7336256 0.78 MAPT (0.46) CYP3A4TSHRACHELMNANPSR1
SCHEMBL2059278 0.78 CYP3A4 (0.65) PTGS1PTGS2CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646149-A N,N*-SUBSTITUTED PIPERAZINE DERIVATIVES; VISION DEFECTS ALCON LABORATORIES, INC. (US) 1997-07-08 US disclosed
EP-0682664-A1 COMPOUNDS HAVING BOTH POTENT CALCIUM ANTAGONIST AND ANTIOXIDANT ACTIVITY AND USE THEREOF AS CYTOPROTECTIVE AGENTS ALCON LABORATORIES, INC. (US) 1995-11-22 EP disclosed
WO-1995015958-A1 COMPOUNDS HAVING BOTH POTENT CALCIUM ANTAGONIST AND ANTIOXIDANT ACTIVITY AND USE THEREOF AS CYTOPROTECTIVE AGENTS ALCON LABORATORIES, INC. (US) 1995-06-15 WO disclosed